Загрузка...

The Epithelial Barrier Model Shows That the Properties of VSL#3 Depend from Where it is Manufactured

BACKGROUND: VSL#3 has been extensively investigated and is currently recommended for the prevention and treatment of chronic pouchitis and ulcerative colitis. Nonetheless, in vitro and in vivo stud-ies have recently shown variability in the VSL#3 efficacy often attributed to the manufacturing proces...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Endocr Metab Immune Disord Drug Targets
Главные авторы: Palumbo, Paola, Lombardi, Francesca, Cifone, Maria Grazia, Cinque, Benedetta
Формат: Artigo
Язык:Inglês
Опубликовано: Bentham Science Publishers 2019
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6425067/
https://ncbi.nlm.nih.gov/pubmed/30360752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1871530318666181022164505
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!